Skip to main content
Log in

Perioperative Strategien zur Regulierung des Sympathikotonus

Strategies for perioperative sympatho-modulation

  • Leitthema
  • Published:
Der Anaesthesist Aims and scope Submit manuscript

Zusammenfassung

Obwohl für verschiedene therapeutische Konzepte zur Verminderung der kardialen perioperativen Morbidität und Mortalität zunehmend Evidenz vorliegt, bleibt die tatsächliche Umsetzung solcher Konzepte im klinischen Alltag oft aus. Zwar ist einem großen Teil der klinisch tätigen Ärzte die wachsende Literatur bekannt; dieses Wissen wird aber nur in einem Teil der Fälle angewendet, selbst wenn allgemein akzeptierte Indikationen bestehen. Die vorliegende Übersichtsarbeit hat deshalb zum Ziel, die Gründe für die mangelnde Umsetzung aufzuzeigen und nochmals die wesentlichen Grundlagen sowie die klinische Bedeutung einzelner Strategien einschließlich des α2-Agonismus, der β-adrenergen Blockade und der Regionalanästhesien zusammenzufassen. Dies insbesondere im Hinblick auf die klinische Anwendung dieser Konzepte in einem allgemeinanästhesiologischen Umfeld. Zudem wird ein Ausblick in die auf „gene profiling“ basierende individualisierte Pharmakotherapie der perioperativen Medizin von morgen gegeben.

Abstract

Despite the growing evidence for the efficacy of different sympatho-modulatory therapies to lower perioperative cardiac morbidity and mortality, such therapeutic strategies are rather infrequently used in daily clinical practice. Most physicians involved in perioperative medicine are aware of the increasing literature related to this topic, but only few comply with current clinical practice guidelines even in the absence of contraindications. This review discusses possible explanations for this reluctance and again summarizes the basic and clinical principles of current sympatho-modulatory therapies including α2-agonism, β-adrenergic antagonism, and regional anesthetic techniques in modern anesthetic practice. In addition, the emerging perioperative concept of a patient-tailored individualized pharmacotherapy based on “gene profiling”, particularly the adrenergic polymorphisms, is discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb.  1
Abb.  2

Literatur

  1. Beta-Blocker Evaluation of Survival Trial Investigators (2001) A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med 344:1659–1667

    Google Scholar 

  2. Amar D, Fleisher M, Pantuck CB et al. (1998) Persistent alterations of the autonomic nervous system after noncardiac surgery. Anesthesiology 89:30–42

    Google Scholar 

  3. Auerbach AD, Goldman L (2002) beta-Blockers and reduction of cardiac events in noncardiac surgery: scientific review. Jama 287:1435–1444

    Google Scholar 

  4. Aybek T, Kessler P, Dogan S et al. (2003) Awake coronary artery bypass grafting: utopia or reality? Ann Thorac Surg 75:1165–1170

    Google Scholar 

  5. Ballantyne JC, Carr DB, deFerranti S et al. (1998) The comparative effects of postoperative analgesic therapies on pulmonary outcome: cumulative meta-analyses of randomized, controlled trials. Anesth Analg 86:598–612

    Google Scholar 

  6. Beattie WS, Badner NH, Choi P (2001) Epidural analgesia reduces postoperative myocardial infarction: a meta-analysis. Anesth Analg 93:853–858

    Article  CAS  PubMed  Google Scholar 

  7. Billinger M, Seiler C, Fleisch M, Eberli FR, Meier B, Hess OM (2001) Do beta-adrenergic blocking agents increase coronary flow reserve? J Am Coll Cardiol 38:1866–1871

    Google Scholar 

  8. Blomberg S, Emanuelsson H, Kvist H et al. (1990) Effects of thoracic epidural anesthesia on coronary arteries and arterioles in patients with coronary artery disease. Anesthesiology 73:840–847

    CAS  PubMed  Google Scholar 

  9. Blomberg S, Ricksten SE (1990) Effects of thoracic epidural anaesthesia on central haemodynamics compared to cardiac beta adrenoceptor blockade in conscious rats with acute myocardial infarction. Acta Anaesthesiol Scand 34:1–7

    Google Scholar 

  10. Boersma E, Poldermans D, Bax JJ et al. (2001) Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. Jama 285:1865–1873

    Google Scholar 

  11. Bonica JJ, Kennedy WF, Akamatsu TJ, Gerbershagen HU (1972) Circulatory effects of peridural block: 3. Effects of acute blood loss. Anesthesiology 36:219–227

    Google Scholar 

  12. Bray MS, Krushkal J, Li L et al. (2000) Positional genomic analysis identifies the beta(2)-adrenergic receptor gene as a susceptibility locus for human hypertension. Circulation 101:2877–2882

    Google Scholar 

  13. Bristow M (2003) Antiadrenergic therapy of chronic heart failure: surprises and new opportunities. Circulation 107:1100–1102

    Google Scholar 

  14. Bristow MR (2000) beta-adrenergic receptor blockade in chronic heart failure. Circulation 101:558–569

    Google Scholar 

  15. Carpenter RL, Caplan RA, Brown DL, Stephenson C, Wu R (1992) Incidence and risk factors for side effects of spinal anesthesia. Anesthesiology 76:906–916

    Google Scholar 

  16. Chamberlain DP, Chamberlain BD (1986) Changes in the skin temperature of the trunk and their relationship to sympathetic blockade during spinal anesthesia. Anesthesiology 65:139–143

    Google Scholar 

  17. Coats AJ (1999) Heart Failure 99—the MOXCON story. Int J Cardiol 71:109–111

    Google Scholar 

  18. Dawood MM, Gutpa DK, Southern J, Walia A, Atkinson JB, Eagle KA (1996) Pathology of fatal perioperative myocardial infarction: implications regarding pathophysiology and prevention. Int J Cardiol 57:37–44

    Google Scholar 

  19. Dobrydnjov I, Axelsson K, Samarutel J, Holmstrom B (2002) Postoperative pain relief following intrathecal bupivacaine combined with intrathecal or oral clonidine. Acta Anaesthesiol Scand 46:806–814

    Google Scholar 

  20. Drysdale CM, McGraw DW, Stack CB et al. (2000) Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci U S A 97:10483–10488

    Google Scholar 

  21. Eagle KA, Berger PB, Calkins H et al. (2002) ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery---executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 105:1257–1267

    Google Scholar 

  22. Ebert TJ (1999) Is gaining control of the autonomic nervous system important to our specialty? Anesthesiology 90:651–653

    Google Scholar 

  23. Favarel-Garrigues JF, Sztark F, Petitjean ME, Thicoipe M, Lassie P, Dabadie P (1996) Hemodynamic effects of spinal anesthesia in the elderly: single dose versus titration through a catheter. Anesth Analg 82:312–316

    Google Scholar 

  24. Fleisher LA, Corbett W, Berry C, Poldermans D (2004) Cost-effectiveness of differing perioperative beta-blockade strategies in vascular surgery patients. J Cardiothorac Vasc Anesth 18:7–13

    Google Scholar 

  25. Fleisher LA, Eagle KA, Shaffer T, Anderson GF (1999) Perioperative- and long-term mortality rates after major vascular surgery: the relationship to preoperative testing in the medicare population. Anesth Analg 89:849–855

    Google Scholar 

  26. Freddolino PL, Kalani MY, Vaidehi N et al. (2004) Predicted 3D structure for the human beta 2 adrenergic receptor and its binding site for agonists and antagonists. Proc Natl Acad Sci U S A 101:2736–2741

    Google Scholar 

  27. Fung JW, Chan SK, Yeung LY, Sanderson JE (2002) Is beta-blockade useful in heart failure patients with atrial fibrillation? An analysis of data from two previously completed prospective trials. Eur J Heart Fail 4:489–494

    Google Scholar 

  28. Gaffney TE, Braunwald E (1963) Importance of the adrenergic nervous system in the support of circulatory function in patients with congestive heart failure. Am J Med 34:320–324

    Google Scholar 

  29. Goldstein S (2004) Beta blocker therapy in African American patients with heart failure. Heart Fail Rev 9:161–167

    Google Scholar 

  30. Gottlieb SS, Fisher ML, Kjekshus J et al. (2002) Tolerability of beta-blocker initiation and titration in the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). Circulation 105:1182–1188

    Google Scholar 

  31. Gouldson PR, Kidley NJ, Bywater RP et al. (2004) Toward the active conformations of rhodopsin and the beta2-adrenergic receptor. Proteins 56:67–84

    Google Scholar 

  32. Gregorini L, Marco J, Farah B et al. (2002) Effects of selective alpha1- and alpha2-adrenergic blockade on coronary flow reserve after coronary stenting. Circulation 106:2901–2907

    Google Scholar 

  33. Groeben H (2000) Effects of high thoracic epidural anesthesia and local anesthetics on bronchial hyperreactivity. J Clin Monit Comput 16:457–463

    Google Scholar 

  34. Hall JA, Kaumann AJ, Brown MJ (1990) Selective beta 1-adrenoceptor blockade enhances positive inotropic responses to endogenous catecholamines mediated through beta 2-adrenoceptors in human atrial myocardium. Circ Res 66:1610–1623

    Google Scholar 

  35. Hayashi Y, Maze M (1994) Drugs affecting adrenoceptors: alpha2-agonists. In: Bowdle TA, et al. The Pharmacologic Basis of Anaesthesiology. Churchill Livingstone, New York, pp 602–623

  36. Jonkers RE, Koopmans RP, Portier EJ, van Boxtel CJ (1991) Debrisoquine phenotype and the pharmacokinetics and beta-2 receptor pharmacodynamics of metoprolol and its enantiomers. J Pharmacol Exp Ther 256:959–966

    Google Scholar 

  37. Kamibayashi T, Maze M (2000) Clinical uses of alpha2 -adrenergic agonists. Anesthesiology 93:1345–1349

    Google Scholar 

  38. Kertai MD, Bax JJ, Klein J, Poldermans D (2004) Is there any reason to withhold beta blockers from high-risk patients with coronary artery disease during surgery? Anesthesiology 100:4–7

    Google Scholar 

  39. Khan ZP, Ferguson CN, Jones RM (1999) alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role. Anaesthesia 54:146–165

    Google Scholar 

  40. Klassen GA, Bramwell RS, Bromage PR, Zborowska-Sluis DT (1980) Effect of acute sympathectomy by epidural anesthesia on the canine coronary circulation. Anesthesiology 52:8–15

    Google Scholar 

  41. Kleinman B (2003) Perioperative beta-blockade requires further study—not standard of care. APSF Newslett 17:55

    Google Scholar 

  42. Lee TW, Grocott HP, Schwinn D, Jacobsohn E (2003) High spinal anesthesia for cardiac surgery: effects on beta-adrenergic receptor function, stress response, and hemodynamics. Anesthesiology 98:499–510

    Google Scholar 

  43. Leopold G (1986) Balanced pharmacokinetics and metabolism of bisoprolol. J Cardiovasc Pharmacol 8 Suppl 11:S16–20

    Google Scholar 

  44. Lilja M, Jounela AJ, Juustila H, Mattila MJ (1980) Interaction of clonidine and beta-blockers. Acta Med Scand 207:173–176

    Google Scholar 

  45. Lindenauer PK, Fitzgerald J, Hoople N, Benjamin EM (2004) The potential preventability of postoperative myocardial infarction: underuse of perioperative beta-adrenergic blockade. Arch Intern Med 164:762–766

    Google Scholar 

  46. Liu SS, McDonald SB (2001) Current issues in spinal anesthesia. Anesthesiology 94:888–906

    Google Scholar 

  47. Loick HM, Schmidt C, Van Aken H et al. (1999) High thoracic epidural anesthesia, but not clonidine, attenuates the perioperative stress response via sympatholysis and reduces the release of troponin T in patients undergoing coronary artery bypass grafting. Anesth Analg 88:701–709

    Google Scholar 

  48. London MJ, Itani KM, Perrino AC Jr et al. (2004) Perioperative beta-blockade: a survey of physician attitudes in the department of Veterans Affairs. J Cardiothorac Vasc Anesth 18:14–24

    Google Scholar 

  49. London MJ, Zaugg M, Schaub MC, Spahn DR (2004) Perioperative beta-adrenergic receptor blockade: physiologic foundations and clinical controversies. Anesthesiology 100:170–175

    Google Scholar 

  50. Mangano DT, Layug EL, Wallace A, Tateo I (1996) Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 335:1713–1720

    Article  CAS  PubMed  Google Scholar 

  51. Mathias CJ, Reid JL, Wing LM, Frankel HL, Christensen NJ (1979) Antihypertensive effects of clonidine in tetraplegic subjects devoid of central sympathetic control. Clin Sci (Lond) 57 [Suppl 5]:425s-428 s

    Google Scholar 

  52. McFalls EO, Ward HB, Moritz TE et al. (2004) Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 351:2795–2804

    Google Scholar 

  53. Meissner A, Rolf N, Van Aken H (1997) Thoracic epidural anesthesia and the patient with heart disease: benefits, risks, and controversies. Anesth Analg 85:517–528

    Google Scholar 

  54. Morita K, Mori H, Tsujioka K et al. (1997) Alpha-adrenergic vasoconstriction reduces systolic retrograde coronary blood flow. Am J Physiol 273:H2746–2755

    Google Scholar 

  55. Nishikawa T, Dohi S (1991) Oral clonidine blunts the heart rate response to intravenous atropine in humans. Anesthesiology 75:217–222

    Google Scholar 

  56. Nishikawa T, Kimura T, Taguchi N, Dohi S (1991) Oral clonidine preanesthetic medication augments the pressor responses to intravenous ephedrine in awake or anesthetized patients. Anesthesiology 74:705–710

    Google Scholar 

  57. Nishina K, Mikawa K, Uesugi T et al. (2002) Efficacy of clonidine for prevention of perioperative myocardial ischemia: a critical appraisal and meta-analysis of the literature. Anesthesiology 96:323–329

    Google Scholar 

  58. Norris EJ, Beattie C, Perler BA et al. (2001) Double-masked randomized trial comparing alternate combinations of intraoperative anesthesia and postoperative analgesia in abdominal aortic surgery. Anesthesiology 95:1054–1067

    Article  Google Scholar 

  59. O’Hara DA, Duff A, Berlin JA et al. (2000) The effect of anesthetic technique on postoperative outcomes in hip fracture repair. Anesthesiology 92:947–957

    Google Scholar 

  60. Oliver MF, Goldman L, Julian DG, Holme I (1999) Effect of mivazerol on perioperative cardiac complications during non-cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). Anesthesiology 91:951–961

    Google Scholar 

  61. Paris A, Philipp M, Tonner PH et al. (2003) Activation of alpha 2B-adrenoceptors mediates the cardiovascular effects of etomidate. Anesthesiology 99:889–895

    Article  Google Scholar 

  62. Park WY, Thompson JS, Lee KK (2001) Effect of epidural anesthesia and analgesia on perioperative outcome: a randomized, controlled Veterans Affairs cooperative study. Ann Surg 234:560–569; discussion 569–571

    Article  CAS  PubMed  Google Scholar 

  63. Peyton PJ, Myles PS, Silbert BS, Rigg JA, Jamrozik K, Parsons R (2003) Perioperative epidural analgesia and outcome after major abdominal surgery in high-risk patients. Anesth Analg 96:548-, table of contents

    Google Scholar 

  64. Poldermans D, Boersma E, Bax JJ et al. (1999) The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 341:1789–1794

    Article  CAS  PubMed  Google Scholar 

  65. Pollard JB (2001) Cardiac arrest during spinal anesthesia: common mechanisms and strategies for prevention. Anesth Analg 92:252–256

    Google Scholar 

  66. Ponhold H, Vicenzi MN (1998) Incidence of bradycardia during recovery from spinal anaesthesia: influence of patient position. Br J Anaesth 81:723–726

    Google Scholar 

  67. Priebe HJ (2003) Perioperative beta-blocker therapy. Anesth Analg Review Course Lectures:60–65

    Google Scholar 

  68. Raby KE, Brull SJ, Timimi F et al. (1999) The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth Analg 88:477–482

    Article  CAS  PubMed  Google Scholar 

  69. Reid JL, Wing LM, Mathias CJ, Frankel HL, Neill E (1977) The central hypotensive effect of clonidine. Studies in tetraplegic subjects. Clin Pharmacol Ther 21:375–381

    Google Scholar 

  70. Rigg JR, Jamrozik K, Myles PS et al. (2002) Epidural anaesthesia and analgesia and outcome of major surgery: a randomised trial. Lancet 359:1276–1282

    Google Scholar 

  71. Rodgers A, Walker N, Schug S et al. (2000) Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised. BMJ 321:1493

    Article  CAS  PubMed  Google Scholar 

  72. Saada M, Duval AM, Bonnet F et al. (1989) Abnormalities in myocardial segmental wall motion during lumbar epidural anesthesia. Anesthesiology 71:26–32

    Google Scholar 

  73. Sabbah HN, Stanley WC, Sharov VG et al. (2000) Effects of dopamine beta-hydroxylase inhibition with Nepicastat on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure. Circulation 102:1990–1995

    Google Scholar 

  74. Salpeter SR, Ormiston TM, Salpeter EE (2002) Cardioselective beta-blockers in patients with reactive airway disease: a meta-analysis. Ann Intern Med 137:715–725

    Google Scholar 

  75. Schmidt M, Lindenauer PK, Fitzgerald JL, Benjamin EM (2002) Forecasting the impact of a clinical practice guideline for perioperative beta-blockers to reduce cardiovascular morbidity and mortality. Arch Intern Med 162:63–69

    Google Scholar 

  76. Scott NB, Turfrey DJ, Ray DA et al. (2001) A prospective randomized study of the potential benefits of thoracic epidural anesthesia and analgesia in patients undergoing coronary artery bypass grafting. Anesth Analg 93:528–535

    Google Scholar 

  77. Shyong EQ, Lucchinetti E, Tagliente TM, Hossain S, Silverstein JH, Zaugg M (2003) Interleukin balance and early recovery from anesthesia in elderly surgical patients exposed to beta-adrenergic antagonism. J Clin Anesth 15:170–178

    Google Scholar 

  78. Sivarajan M, Amory DW, Lindbloom LE (1976) Systemic and regional blood flow during epidural anesthesia without epinephrine in the rhesus monkey. Anesthesiology 45:300–310

    Google Scholar 

  79. Small KM, McGraw DW, Liggett SB (2003) Pharmacology and physiology of human adrenergic receptor polymorphisms. Annu Rev Pharmacol Toxicol 43:381–411

    Google Scholar 

  80. Smiley RM, Kwatra MM, Schwinn DA (1998) New developments in cardiovascular adrenergic receptor pharmacology: molecular mechanisms and clinical relevance. J Cardiothorac Vasc Anesth 12:80–95

    Google Scholar 

  81. Snapir A, Heinonen P, Tuomainen TP et al. (2001) An insertion/deletion polymorphism in the alpha2B-adrenergic receptor gene is a novel genetic risk factor for acute coronary events. J Am Coll Cardiol 37:1516–1522

    Article  CAS  PubMed  Google Scholar 

  82. Soriano JB, Hoes AW, Meems L, Grobbee DE (1997) Increased survival with beta-blockers: importance of ancillary properties. Prog Cardiovasc Dis 39:445–456

    Google Scholar 

  83. Stenseth R, Berg EM, Bjella L, Christensen O, Levang OW, Gisvold SE (1993) The influence of thoracic epidural analgesia alone and in combination with general anesthesia on cardiovascular function and myocardial metabolism in patients receiving beta-adrenergic blockers. Anesth Analg 77:463–468

    Google Scholar 

  84. Talke P, Li J, Jain U et al. (1995) Effects of perioperative dexmedetomidine infusion in patients undergoing vascular surgery. The Study of Perioperative Ischemia Research Group. Anesthesiology 82:620–633

    Google Scholar 

  85. Tan CM, Wilson MH, MacMillan LB, Kobilka BK, Limbird LE (2002) Heterozygous alpha 2A-adrenergic receptor mice unveil unique therapeutic benefits of partial agonists. Proc Natl Acad Sci U S A 99:12471–12476

    Google Scholar 

  86. Theodorou AE, Mistry H, Davies SL, Yamaguchi Y, Horton RW (1987) Platelet alpha 2-adrenoceptor binding and function during the menstrual cycle. J Psychiatr Res 21:163–169

    Google Scholar 

  87. Tzivoni D, Medina A, David D, Barzilai Y, Brunel P (1998) Effect of metoprolol in reducing myocardial ischemic threshold during exercise and during daily activity. Am J Cardiol 81:775–777

    Google Scholar 

  88. Urban MK, Markowitz SM, Gordon MA, Urquhart BL, Kligfield P (2000) Postoperative prophylactic administration of beta-adrenergic blockers in patients at risk for myocardial ischemia. Anesth Analg 90:1257–1261

    Google Scholar 

  89. Urwin SC, Parker MJ, Griffiths R (2000) General versus regional anaesthesia for hip fracture surgery: a meta-analysis of randomized trials. Br J Anaesth 84:450–455

    Google Scholar 

  90. VanDenKerkhof EG, Milne B, Parlow JL (2003) Knowledge and practice regarding prophylactic perioperative beta blockade in patients undergoing noncardiac surgery: a survey of Canadian anesthesiologists. Anesth Analg 96:1558–1565, table of contents

    Google Scholar 

  91. Wallace AW, Galindez D, Salahieh A et al. (2004) Effect of clonidine on cardiovascular morbidity and mortality after noncardiac surgery. Anesthesiology 101:284–293

    Google Scholar 

  92. Warltier DC (1998) Beta-adrenergic-blocking drugs: incredibly useful, incredibly underutilized. Anesthesiology 88:2–5

    Google Scholar 

  93. Wijeysundera DN, Naik JS, Beattie WS (2003) Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: a meta-analysis. Am J Med 114:742–752

    Google Scholar 

  94. Zaugg M, Schaub MC (2004) Cellular mechanisms in sympatho-modulation of the heart. Br J Anaesth 93:34–52

    Google Scholar 

  95. Zaugg M, Schaub MC (2005) Genetic modulation of adrenergic activity in the heart and vasculature: Implications for perioperative medicine. Anesthesiology 102:429–446

    Google Scholar 

  96. Zaugg M, Schaub MC, Pasch T, Spahn DR (2002) Modulation of beta-adrenergic receptor subtype activities in perioperative medicine: mechanisms and sites of action. Br J Anaesth 88:101–123

    Article  CAS  PubMed  Google Scholar 

  97. Zaugg M, Schulz C, Wacker J, Schaub MC (2004) Sympatho-modulatory therapies in perioperative medicine. Br J Anaesth 93:53–62

    Google Scholar 

  98. Zaugg M, Tagliente T, Lucchinetti E et al. (1999) Beneficial effects from beta-adrenergic blockade in elderly patients undergoing noncardiac surgery. Anesthesiology 91:1674–1686

    Google Scholar 

  99. Zaugg M, Tagliente T, Silverstein JH, Lucchinetti E (2003) Atenolol may not modify anesthetic depth indicators in elderly patients—a second look at the data. Can J Anaesth 50:638–642

    Google Scholar 

Download references

Danksagung

Teile der vorliegenden Arbeit wurden durch Beiträge des Schweizerischen Nationalfonds (3200–063417.00 und 3200130–1039880/1), der Schweizerischen Herzstiftung und der Schweizerischen Gesellschaft für Anästhesiologie und Reanimation finanziell unterstützt. Die Autoren danken Frau Dr. med. Ursula Dittli und Frau Dr. phil. Eliana Lucchinetti für die Durchsicht und Korrektur des Manuskripts.

Interessenkonflikt:

Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Zaugg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wacker, J., Pasch, T., Schaub, M.C. et al. Perioperative Strategien zur Regulierung des Sympathikotonus. Anaesthesist 54, 303–318 (2005). https://doi.org/10.1007/s00101-005-0826-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00101-005-0826-1

Schlüsselwörter

Keywords

Navigation